Nurix Therapeutics Inc (NRIX) — Cash Flow Reinvestment Rate
Nurix Therapeutics Inc (NRIX) has a Cash Flow Reinvestment Rate of 0.64x as of November 2023, reinvesting $16.96 Million (capex $2.58 Million plus investments $-14.37 Million) from operating cash flow of $26.69 Million. See cash generation quality of Nurix Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nurix Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Nurix Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see NRIX operating cash flow.
Annual Cash Flow Reinvestment Rate for Nurix Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for Nurix Therapeutics Inc. See how financially flexible is Nurix Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 16.89x | $10.15 Million | $601.00K | $1.65 Million | — |